Company / Operating Cash Flow
Progyny Operating Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$210.2M
FY2025
5-year range
$26.0M / $210.2M
FY2021-FY2025
Trend
+17.4%
vs FY2024
Sector context
#83 of 158
Health Care
What the data says
At $210M, Progyny's operating cash flow ranks #83 of 158 in the Health Care sector. Operating Cash Flow has fluctuated over the past 9 years, ranging from -$9M in FY2017 to $210M in FY2025.
Based on SEC 10-K filings.
$210M in FY2025 with a 5-year CAGR of +42.2%.
Improved from $189M to $210M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +37.8%
- 5-Year CAGR
- +42.2%
- 10-Year CAGR
- -
Sector benchmark
#83 of 158 in Health CareTop 53% of 158This company $210.2M Sector average $1.0B
▼
-79.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +42.2%, indicating consistent growth.
- In FY2025, operating cash flow increased 17.4% year-over-year.
- Ranks #83 out of 158 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $210.2M | +17.4% |
| FY2024 | $179.1M | -5.1% |
| FY2023 | $188.8M | +134.9% |
| FY2022 | $80.4M | +208.8% |
| FY2021 | $26.0M | -28.1% |
| FY2020 | $36.2M | +2460.0% |
| FY2019 | -$1.5M | -167.5% |
| FY2018 | $2.3M | +124.0% |
| FY2017 | -$9.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026